Sana Biotechnology (SANA) Long-Term Investments (2020 - 2023)

Sana Biotechnology's Long-Term Investments history runs 4 years deep, the most recent figure standing at $5.8 million for Q1 2023.

• In Q1 2023, Long-Term Investments fell 95.98% year-over-year to $5.8 million; the TTM figure through Mar 2023 stood at $5.8 million (down 95.98% YoY), while the FY2022 annual figure was $10.1 million, down 94.87% from the prior year.
• Long-Term Investments came in at $5.8 million for Q1 2023 at Sana Biotechnology, down from $10.1 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $262.4 million in Q3 2021 to a low of $5.8 million in Q1 2023.
• A 4-year average of $87.3 million and a median of $55.8 million in 2020 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments surged 570.52% in 2022 and slumped 95.98% in 2023, its largest moves.
• Sana Biotechnology's Long-Term Investments stood at $33.7 million in 2020, then soared by 480.72% to $195.9 million in 2021, then tumbled by 94.87% to $10.1 million in 2022, then sank by 42.05% to $5.8 million in 2023.
• According to Business Quant data, Long-Term Investments over the past three periods registered $5.8 million, $10.1 million, and $25.8 million for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison